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Summary 
Thrombin is a serine protease that is released at sites of vascular injury and exerts a variety of 
biologic effects on different cell types. Thrombin is postulated to play a role in the pathogenesis 
of a number of diseases including atherosclerosis, since it activates  vascular smooth muscle and 
endothelial cells. Thrombin mediates these effects through a specific receptor that is upregulated 
in vascular cells in atherosclerosis. Atherosclerosis and glomerulosclerosis are characterized by 
the presence of monocyte-macrophages in the lesions.  Monocyte chemotactic protein (MCP-1) 
is believed to be an important mediator of monocyte recruitment to the tissue and can be induced 
in a broad variety of cells including mesangial ceils. We studied the effect of thrombin on MCP-1 
production and gene expression in well-characterized human mesangial cells, vascular pericytes 
that play a central role in fibrosis of the glomerular microvascular bed. ot thrombin stimulates 
MCP-1 production and gene expression in mesangial cells in a dose- and time-dependent manner. 
Experiments with diisopropylfluorophosphate thrombin and 3' thrombin demonstrate that this 
thrombin effect requires both receptor binding as well as catalytic activity, features consistent 
with the known properties of the recently characterized and cloned thrombin receptor. Moreover, 
a human thrombin receptor activating peptide (TRAP1-7)  also stimulates MCP-1 production. 
Northern blot analysis demonstrated that mesangial ceils express an mRNA transcript that hybridizes 
with labeled human thrombin receptor cDNA.  These data describe a novel biologic activity 
of thrombin and suggest an additional mechanism by which this coagulation factor may participate 
in the progression of glomerulosclerosis, and by analogy, atherosclerosis. 
T 
hrombin is a serine protease released at sites of vascular 
injury during activation of both intrinsic or extrinsic 
coagulation pathways. In addition to its central role in clot- 
ting, thrombin exerts a variety of cell-activating functions 
(1). It is mitogenic for fibroblasts, vascular smooth muscle 
cells and glomerular mesangial cells (2-4).  Thrombin also 
stimulates  platelet-derived  growth  factor  production  and 
monocyte adhesion in endothelial cells (5-7). These findings 
indicate a potential role for thrombin in the development and 
progression of atherosclerosis. The observation (8) that the 
recently cloned thrombin receptor is widely expressed within 
human atherosderotic lesions in vivo supports this conten- 
tion. Mesangial cells are vascular pericytes within the glo- 
merular microvascular bed. Proliferation of these cells and 
mesangial matrix expansion are characteristic of glomerulo- 
sclerosis  and resemble the intimal thickening and smooth 
muscle cell proliferation present in atherosclerosis (9).  An- 
other essential feature of both pathological processes is the 
presence of monocytes in the lesions (9). Once in the arterial 
wall or in the mesangial area, monocytes represent a reser- 
voir and a source of cytokines or growth factors promoting 
and/or maintaining the activation of resident cells (10). The 
mechanisms by which monocytes are recruited to the blood 
vessel wall and the mesangial area, to participate in the devel- 
opment of atherosclerotic or glomerulosclerotic lesions,  re- 
main to be defined. Monocyte chemotactic protein 1 (MCP- 
1) is a potent and specific chemotactic factor for monocytes 
(11). MCP-1 expression has recently been identified in human 
and experimental atherosclerotic lesions, indicating its potential 
role in the recruitment of monocytes into the lesions (12-14). 
Mesangial cells in culture produce MCP-1 constitutively and 
in response to different cytokines (15, 16). In this study, we 
examined the effect of thrombin on MCP-1 production and 
gene expression in well-characterized human mesangial cells. 
The results demonstrate a stimulatory effect of thrombin on 
MCP-1 protein and gene expression that is dependent on both 
intact binding site and catalytic activity. This novel biologic 
effect of thrombin may be of fundamental importance in the 
recruitment of monocytes and therefore in the development 
and progression of focal or other forms of glomeruloscle- 
rosis  and, perhaps in analogy, atherosclerosis, 
Materials and Methods 
Materials.  Highly purified human c~ thrombin, (2,750 U/mg) 
diisopropylfluorophosphate (DIP) thrombin and 3' thrombin (sp 
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State Department of Health, Wadsworth Center for Laboratories 
and Research, Albany, NY).  Human c~ thrombin  (sp act 4,000 
U/rag) was purchased from Sigma Chemical Co. (St. Louis, MO). 
Thrombin solutions were tested for endotoxin content by the litmus 
amebocyte lysate assay (Association  of Cape Cod, Inc., Woods Hole, 
MA) and found to contain <0.1 ng/ml LPS. The human thrombin 
receptor  activating  peptide  NH2-Ser-Phe-Leu-Leu-Arg-Asn-Pro- 
COOH (TRAP1-7)  was synthesized using F-moc chemistry on a 
peptide synthesizer (model 430A; Applied Biosystems, Inc., Foster 
City, CA) in the University of Texas Health Science  Center In- 
stitutional Protein Core Facility and purified using reverse phase- 
high pressure liquid  chromatography.  The purified peptide was 
verified  using amino acid compositional and mass spectrometry. 
Tissue culture materials were obtained from GIBCO BILL (Gaithers- 
burg,  MD).  32p-CTP (3,000 Ci/mmol) was obtained from New 
England Nuclear (Boston, MA) and 12SI-Bolton-Hunter  Reagent 
from ICN Radiochemicals (Irvine, CA). 
Mesangial Cell Culture.  Human mesangial cells were cultured 
from glomeruli isolated from normal human kidneys judged un- 
suitable for transplantation  or normal areas  of surgical nephrec- 
tomy samples. The cells have been extensively characterized and 
their identity was confirmed by immunohistochemical staining and 
by electron microscopy as detailed previously (17). The cells were 
grown in Waymouth's medium containing 17% FCS.  For alt the 
experiments,  the cells were used between passages  6 and  10. 
Measurement of MCP-1 by Radioimmunoassay.  MCP-1 levels were 
measured by a specific and sensitive RIA using specific anti-MCP-1 
antiserum  as  described previously (18).  Highly purified human 
MCP-1  (15,000  tool  wt  form)  was  isolated  from  serum  free- 
conditioned medium of a human U105 tumor cell line using a com- 
bination of aifinity chromatography on orange A-Sepharose, ion 
exchange, and reverse phase HPLC. 2-5/~g of the purified protein 
was labeled  with  ~zsI using  the  Bolton-Hunter  reaction  as  de- 
scribed previously (18). Specific activities of 100-300 cpm/pg of 
protein were routinely obtained.  Protein-associated counts were 
>90%  precipitable in  10%  TCA. In a preliminary study, it was 
determined  that sodium sulfate at a final concentration  of 15% 
wt/vol would precipitate <10% of ~2SI-MCP-1 in the presence of 
nonimmune serum, whereas >90% could be salt precipitated after 
reaction with 1:100 dilution of the specific rabbit antiserum to ba- 
boon MCP-1. Based on these observations, the following standard 
protocol was adopted for a RIA. To a 150-/~1 volume of the test 
solution  was added  50/~I of I~I-MCP-1 (5  x  105 cpm/ml) in 
assay buffer (150 mM NaC1,  10 mM Tris-HC1,  pH 8.0,  1 mM 
EDTA, and 0.5% human serum albumin) and 100/zl of the rabbit 
antibody to MCP-1  (diluted  1:300 in assay buffer). The samples 
were incubated at 37~  for 2 h and then 100/~1 of 60% calf serum 
as carrier and I ml of 19.6% sodium sulfate were added and incu- 
bation continued at room temperature. The tubes were centrifuged 
at 1,500g for 20 rain, the supernatant was discarded, and the ac- 
tivity in the precipitate was counted. All determinations were made 
in triplicate; replicate values varied by <10%. Under these condi- 
tions, "~60% of the total added counts were bound maximally (Bo). 
Pooled serum-free medium conditioned by cultured human U105 
tumor cells was used as a working standard. Dilutions of the stan- 
dard were made in assay buffer and determinations made in tripli- 
cates as with the test samples.  A plot of the logit transformation 
of the proportion of the tracer bound (B/Bo) against the logarithm 
of the concentration of the standard was linear (r  2 >0.95) over the 
standard range of 5-70 ng/ml MCP-1. Each working standard pool 
(60-80 ng/ml MCP-1) was standardized with freshly prepared highly 
purified MCP-1 quantitated as before. Where necessary, test samples 
were diluted in assay buffer to bring them into the linear range 
of the curve. To determine the effect  of c~, 3' or DIP thrombin 
and  TRAP~_7 on MCP-1  protein production,  confluent  human 
mesangial cells in 12-well dishes were rinsed twice and incubated 
in serum-free medium with or without the indicated doses of highly 
purified human ~, DIP, or 3" thrombin. At the indicated time points, 
the medium was collected and assayed for MCP-1 using the RIA 
described above. Each experimental point was determined in dupli- 
cate or triplicate. 
RNA Isolation and Northern Blotting.  Total RNA was prepared 
from human mesangial cells by lysis in guanidine isothiocyanate 
and centrifugation on cesium chloride gradients as previously de- 
scribed.  Poly(A) +  RNA was selected by oligo (dT) cellulose chro- 
matography. For Northern blotting, total RNA or poly(A)*RNA 
was electrophoresed through 1% agarose-formaldehyde gel, trans- 
ferred to GeneScreen (New England Nuc/ear), and prehybridized 
at 42~  for 2 h in 50% formamide, 0.5% SDS, 2x  Pipes-NaC1- 
EDTA buffer, and 0.1 mg/ml salmon sperm DNA. Baboon MCP-1 
cDNA or human thrombin receptor cDNA (19) was labeled  by 
random  priming  using  a  commercial  kit  (Amersham  Corp., 
Arlington  Heights,  IL) and  [J2P]dCTP  (3,000  Ci/mmol).  The 
probes (2  x  106 cpm/ml) were added to 10 ml of prehybridiza- 
tion solution, and the blots were hybridized for 16 h at 42~  Blots 
were then washed and autoradiography was performed with Kodak 
x-ray film and intensifying screens at  -70~  The MCP-1 probe 
was then removed by boiling, and the same blot was rehybridized 
to a cDNA encoding the ribosomal protein 36B4 (20). 
Statistical Analysis.  Comparison of MCP-1 secretion in the pres- 
ence or absence of thrombin was performed by Student's t test for 
paired data. 
Results 
We  first examined  the  effect of cr  thrombin  on MCP-1 
secretion using a specific and sensitive RIA.  In response to 
different  concentrations  of o~ thrombin,  there  was a  dose- 
dependent  increase of MCP-1  released into the media (Fig. 
1). A  significant increase over basal values was observed at 
1 U/ml thrombin.  Peak effect occurred at 5 U/ml;  concen- 
trations of thrombin as high as 20 U/ml had no additional 
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Figure  I.  Dose-presponse  for the effect  of o~ thrombin on MCP-I 
production.  Human mesangial cells  were grown to  confluence  in 12-well 
plates. The cells were rinsed and incubated in serum-free medium with 
different concentrations of or thrombin. After 24 h, the medium was col- 
lected and assayed  for MCP-1 by RIA as described in Materials and Methods. 
Data are expressed as mean  _+ SEM from four to seven separate experi- 
ments. (*) p <0.05 compared with control. 
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effect on MCP-1 production.  As shown in Fig. 2 A, a signi- 
ficant increase in MCP-1 production in response to oe thrombin 
was detectable at 12 h  and continued  to increase for at least 
48  h  after its  addition.  To determine  if thrombin-induced 
MCP-1 release is due to de novo protein synthesis, we exam- 
ined the effect of thrombin  on MCP-1  mRNA  levels.  Fig. 
3 shows that thrombin induced MCP-1 gene expression. The 
stimulator), effect occurred as early as 2 h  (twofold), reached 
a  maximum at 8  h  (10-fold),  and  was  still present  at  24  h 
(fivefold) after the addition  of thrombin.  To investigate if c~ 
thrombin-induced MCP-1 gene expression and protein secre- 
tion  were  dependent  on  its  enzymatic  activity,  derivatives 
of thrombin modified at the catalytic or binding  sites were 
tested.  DIP-treated  ol  thrombin  is blocked  at  the  catalytic 
site, but can still bind the receptor via the anion binding exo- 
TRAP  Thrombin 
Figure  2.  (-4)  Time course for the 
effect of thrombin on MCP-1 produc- 
tion.  Human  mesangial cells were 
grown in 12-well  plates, rinsed, and in- 
cubated in serum-free  medium with 2.5 
U/ml of thrombin.  The medium was 
collected at 12, 24, and 48 h and assayed 
for MCP-I  by RIA  as  described in 
Materials and Methods. Data are ex- 
pressed as mean +  SEM from three or 
four separate experiments. (*) p <0.05 
compared with control.  (B) Effect of 
TtLAP1-7 on MCP-1 production.  Ex- 
periments  were carried out  as in A. 
Thrombin (2.5 U/ml) or TRAP1_7 (50 
pM) was added and medium collected 
at 24 h for MCP-1 assay. Data are ex- 
pressed as mean _+ SEM from three sep- 
arate experiments. (*) p <0.05. 
site. 3' thrombin on the other hand has the binding site dis- 
rupted but  still has an active catalytic  site (3,  19).  Neither 
DIP nor 3' thrombin treatment of mesangial cells stimulated 
MCP-1  release (Fig.  4) or influenced MCP-1  mRNA  levels 
(Fig. 5) when used in equimolar concentrations to ce thrombin 
(1.7  x  10 -s or 0.625/~g/ml).  These data indicate that both 
proteolytic activity and intact binding  exosites are required 
for thrombin stimulation of MCP-1 production and gene ex- 
pression. These data also suggest that the effect of thrombin 
on MCP-1  production by mesangial cells may be mediated 
by a  specifc  cell  surface  thrombin  receptor  similar  to  that 
recently characterized by Vu et al.  (19).  Evidence that  this 
receptor is involved in mediating thrombin's effect is provided 
by the experiment demonstrating that TRAPt-7 (SFFLRNP), 
at concentrations of 50/~M also stimulated MCP-1 produc- 
tion in cultured human mesangial cells (Fig. 2 B). Northern 
blot  hybridization  of poly(A) + R.NA  from  mesangial  cells 
with  a  labeled  human  thrombin  receptor  cDNA,  detected 
a  single  mRNA  species  of 3.5  kb,  in  agreement  with  the 
size of thrombin receptor mRNA  detected in other cell types 
(Fig.  6). 
Figure  3.  Time course for the effect of thrombin on MCP-1 gene ex- 
pression. Confluent mesangial cells were washed and incubated in serum- 
deprived medium for 48 h before exposure to thrombin (2.5 U/ml). At 
the indicated time points, the cells were harvested and RNA was isolated. 
Control represents RNA isolated at time zero. Each lane contains 15 $g 
of total RNA. After hybridization with MCP-1 cDNA, the probe was 
removed  by boiling and the blot was rehybridized to a 36B4 cDNA. Blots 
were exposed to Kodak Xomat film with intensifying screens overnight 
at -70~  for the MCP-1 cDNA and for 10 d for 36B4 cDNA. Compared 
with control (time zero), thrombin elicited two-, seven-, ten-, nine-, and 
fivefold increase at 2, 4,  8,  16 and 24 h, respectively. 
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Figure  4.  Effect  of 3" thrombin and DIP thrombin on MCP-1 produc- 
tion. Confluent mesangial cells were rinsed and incubated in serum-free 
medium in the presence  of c0, 3' or DIP-thrombin. After 24 h, the medium 
was coflected and assayed for MCP-1 by RIA. Data represent mean  + 
SEM from three separate  experiments. (*)p <0.05 compared with control 
1739  Grandaliano  et al.  Brief Definitive Report Figure  5.  Effect  of  DIP thrombin (bottom right) and 3' thrombin (bottom 
left) on MCP-1 gene  expression. Confluent  mesangial  cells  were  incubated 
in serum-free medium for 48 h before the addition of o~ (2.5 U/ml), 3" 
(0.625 #g/ml), or DIP thrombin (0.625/xg/ml). After 8 h the cells  were 
harvested and RNA was isolated. Each  lane contains 15/~g of total RNA. 
Blots  were  hybridized  with MCP-1  cDNA, washed  and exposed  to Kodak 
Xomat films with intensifying screens overnight at  -70~ 
Discussion 
In this study, we describe a novel biologic effect of thrombin: 
stimulation of MCP-1 production and gene expression. This 
effect of thrombin  is demonstrated in cultured human glo- 
merular mesangial cells, vascular pericytes that acquire effector 
functions  during  glomerular  injury.  The  rapid  increase  in 
mRNA levels in response to thrombin suggest that increased 
transcription is an important mechanism of increased MCP  ol 
production.  However, changes  in  mRNA  stability and/or 
regulation of MCP-1 protein translation cannot be excluded. 
Stimulation of MCP-1 expression by thrombin requires both 
an  intact  receptor binding  site  on the molecule and  enzy- 
matic  activity,  consistent  with  the  properties  required  for 
stimulation  of the recently cloned thrombin  receptor (19). 
Moreover, we demonstrate that the synthetic peptide human 
TRAP1-7 with sequences similar to the amino acid terminus 
of the cleaved human thrombin receptor also stimulate MCP-1 
production,  and that human mesangial cells predominantly 
express a single mRNA transcript upon hybridization with 
labeled cDNA of the recently cloned thrombin receptor (3, 
19).  Therefore,  this biologic activity of thrombin,  at  least 
in part, appears to be mediated by a specific thrombin receptor. 
These data establish an important link between the clotting 
cascade and monocyte recruitment to this microvascular bed. 
Monocyte infiltration is a prominent  feature of both human 
and experimental forms of glomerular injury (21, 22). Histo- 
chemical and ultrastructural  studies in human kidney biop- 
sies have identified  monocytes within  the mesangium  and 
sometimes in direct contact with mesangial cells in a variety 
of renal  diseases,  including  focal  glomerulosclerosis  acute 
proliferative glomerulonephritis and crescentic forms of glo- 
merulonephritis (21, 22). The generation of thrombin in the 
glomerular  microenvironment  is suggested by the presence 
of fibrin deposition and microthrombi  within  the glomer- 
Figure 6.  Human  glomerular mes- 
angial cells  express  thrombin receptor 
mRNA.  5 #g  of poly(A)  + KNA 
from mesangial cells were size frac- 
tionated  through  a  1%  agarose- 
formaldehyde and transferred onto a 
nylon membrane. The blot was hy- 
bridized with a 32p-labeled human 
thrombin receptor cDNA, washed, 
and exposed to Kodak Xomat film 
with intensifying  screens  overnight at 
70~  Numbers on the right repre- 
sent sizes in kilobases  of KNA stan- 
dards run in the same  gel and stained 
with ethidium bromide. 
ular capillaries  in severe inflammatory and vascular diseases 
of the kidney, including transplant  rejection (23, 24). In ad- 
dition,  a positive correlation between fibrin deposition and 
monocyte infiltration was observed in a large series of human 
renal biopsies (25). In the rat remnant kidney model, charac- 
terized by progressive renal injury,  monocytes are detected 
in glomeruli  as early as  2 wk after renal  ablation  (26).  In 
this model, Floege et al.  (26) reported that activation of the 
coagulation system precedes the influx of monocytes. These 
observations suggest a role for certain factor(s) of the coagu- 
lation cascade in monocyte recruitment.  Whereas fibrin it- 
self or fibrin degradation product(s) have been implicated as 
mediators of monocyte influx to the glomerular vascular bed, 
in rabbits with nephrotoxic nephritis,  defibrination reduced 
glomerular fibrin deposition but had no effect on monocyte 
accumulation within the mesangial  area (27).  Thrombin  is 
not the only inducer of MCP-1 production by mesangial cells. 
Mesangial cell production of MCP-1 is stimulated in response 
to proinflammatory cytokines and lipoproteins (14,  15, 28). 
It is interesting  to note that  thrombin  itself is chemotactic 
for monocytes (29),  hence activation  of mesangial  cells by 
thrombin to release MCP-1 would result in further recruit- 
ment and activation of monocytes with subsequent amplifica- 
tion of the inflammatory response.  To our knowledge, this 
is the first report to demonstrate the stimulation of MCP-1 
production by thrombin  in any cell type. Our finding may 
have major implications as to the role of thrombin in mono- 
cyte recruitment to other micro or macro vascular beds. MCP-1 
gene expression is also upregulated by thrombin in glomer- 
ular vascular  endothelial cells (Fouqueray, B., G. Grandaliano 
and H.  E.  Abboud,  unpublished  observation). 
The authors thank Dr. Shaun Coughlin  for providing the human thrombin receptor cDNA. The authors 
also acknowledge Kathleen Woodruff and Sergio Garcia for expert  technical help, and Laurie Baker for 
typing the manuscript. 
This work was supported in part by the VA Medical Research Service and National  Institutes  of Health 
grants DK-33665, DK-43988, and HL-26890. G. Grandaliano is a recipient of a National Kidney Founda- 
tion  Fellowship grant. 
1740  Thrombin  and Monocyte Chemotactic Protein 1 Expression Address correspondence to Dr. Hanna E. Abboud, Department  of Medicine, Division of Nephrology, 
The University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, 
TX 78284-7882. 
Received for publication  9  September  1993 and in revised form  26January  1994. 
References 
1.  Shuman, M.A. Thrombin-cellular  interactions. 1986. Ann. N.Y. 
Acad. Sci. 485:228. 
2.  Chambard, J.C.,  S. Paris, G. EAllemain, and J. Pouyssegur. 
1987. Two growth factor signalling  pathways  in fibroblasts  dis- 
tinguished by pertussis toxin. Nature (Lond.). 326:800. 
3.  McNamara, C.A., I.J. Sarembock, L.W. Gimple, J.W. Fenton 
II, S.R. Coughlin, and G.K. Owens. 1993. Thrombin stimu- 
lates proliferation of cultured rat aortic smooth muscle cells 
by a proteolytically activated receptor, j.  Ctin. Invest. 91:94. 
4.  Shultz, P.J., T.C. Knauss, P. Mene, and H.E. Abboud. 1989. 
Mitogenic signals for thrombin in mesangial cells: regulation 
ofphospholipase C and PDGF genes. Am.J. Physiol. 257:F366. 
5.  Harlan, J.M., P.J. Thompson, R. Ross, and D.F. Bowen-Pope. 
1986. c~ thrombin induces release of platelet-derived growth 
factor-like molecule(s) by cultured human endothelial cells.J. 
Cell Biol. 103:1129. 
6.  Daniel, T., C. Gibbs, D.E Milfey, M.R. Garovoy, and L.T. 
Williams. 1986. Thrombin stimulates c-sis gene expression in 
microvascuhr endothelial cells. J. Biol. Chem.  261:9579. 
7.  Shankar, R., C.A.  de la Motte,  and P.E. DiCorleto.  1992. 
Thrombin stimulates PDGF production and monocyte adhe- 
sion through distinct  intracellular pathways in human  en- 
dothelial cells. Am. J. Physiol. 262:C199. 
8.  Nelken, N.A., S.J. Soifer,  J. O'Keefe, T.-K.H. Vu, I.F. Charo, 
and S.R. Coughlin.  1992. Thrombin  receptor expression in 
normal and atherosclerotic human arteries,  j. Clin. Invest, 90: 
1614. 
9.  Diamond, J.R., and M.J. Karnovsky.  1988. Focal  and segmental 
glomerulosclerosis: analogies to  atherosclerosis. Kidney Int. 
33:917. 
10.  Nathan, C.F. 1987. Secretory  products ofmacrophages.J. Clin. 
Invest. 79:319. 
11. Leonard, E.J.,  and T. Yoshimura. 1990. Human monocyte 
chemoattractant protein-1 (MCP-1), ImmunoL  Today, 11:97. 
12. Yla-Herttuala, S., B.A. Lipton, M.E. Rosenfeld, T. Sarkioja, 
T. Yosbimura, E.J. Leonard,  J.L. Witztum, and D. Steinberg. 
1991. Expression of monocyte chemoattractant protein 1 in 
macrophage-rich areas of  human and rabbit atherosclerotic  le- 
sions. Proa Natl.  Acad. Sci. USA.  88:5252. 
13.  Yu, X., S. Dluz, D.T. Graves, L. Zhang, H.N. Antoniades, 
W. Hollander, S. Prusty, A.J. Valente, Collin J. Schwartz, and 
G.E. Soneshein. 1992. Elevated  expression of monocyte chemo- 
attractant protein I by vascular smooth muscle cells in hyper- 
cholesterolemic  primates. Proc. Natl. Acad. Sci. USA. 89:6953. 
14.  Nelken, N.A., S.R. Coughlin, D. Gordon, and J.N. Wilcox. 
1991. Monocyte  chemoattractant  protein-1 in human atheroma- 
tous plaques, j.  Clin.  Invest. 88:1121. 
15.  Satriano, J.A., K. Hora, Z. Shan, E.R. Stanley, T. Mori, and 
D. Schlondorff. 1993. Regulation of monocyte chemoattrac- 
tant protein-1 and macrophage colony-stimulating factor-1 by 
IFN-'y, tumor necrosis factor-a,  IgG aggregates, and cAMP 
in mouse mesangial cells.  J. Immunol.  150:1971. 
16.  Rovin,  B.H.,  T.  Yoshimura, and L.  Tan. 1992. Cytokine- 
induced production of monocyte chemoattractant protein-1 by 
cultured human mesangial cells.  J.  lmmunol.  148:2148. 
17.  Shultz, P.J., P.E. DiCorleto, B.J. Silver, and H.E. Abboud. 
1988. Human mesangial cells express PDGF  mRNA and 
proliferate in response to PDGF. Am. J. Physiol. 255:F674. 
18.  Marra, E, A.J. Valente, M. Pinzani, and H.E. Abboud. 1993. 
Cultured  human  liver fat-storing  ceils produce  monocyte 
chemotactic protein-1. J.  Clin. Invest. 92:1674. 
19.  Vu, T.K.J., D.T. Hung, V.I. Wheaton, and S.R. Coughlin. 
1991. Molecular cloning of a functional cloning receptor re- 
veals a novel  proteolytic mechanism  of  receptor activation. Cell. 
64:1057. 
20. Basset, P., J.P. Bellocq, C. Wolf, I. Stoll, E  Hutin, J.M. 
Limacher, O.L. Podhajcer, M.P. Chenard, M.C. Rio, and P. 
Chambon.  1990. A novel metallaproteinase gene specifically 
expressed in stromal cells of  breast carcinomas. Nature (Lond.). 
348:699. 
21.  Main, I.W., D.J. Nikolic-Paterson, and R.C. Atkins. 1992. T 
cells and macrophages and their role in renal injury. Seminars 
in Nephrology.  12:395. 
22.  Holdsworth, S.R., and P.G. Tipping. 1991. Cell-mediated  Im- 
munity in Glomerulonephritis.  Immunology of Renal Diseases. 
C.D. Hingham and M.A. Pusey, editors. Kluwer Academic 
Publishers, Norwell,  MA. 97-122. 
23.  Glassock,  R.J., S.G. Adler, H.J. Ward, and A.H. Cohen. 1991. 
Primary glomerular diseases, In The Kidney. B. Brenner and 
EC. Rector, editors. W.B. Saunders Co., Philadelphia. 1182- 
1279. 
24.  Hancock, W., and R. Atkins. 1985. Activation of  coagulation 
pathways and fibrin deposition in human glomerulonephritis. 
Seminars in Nephrology. 5:69. 
25.  Ferrario, F., A. Castiglione, G. Colasanti, G.B. Di Belgioioso, 
S. Bertoli, and G. D'Amico. 1985. The detection of monocytes 
in human glomerulonephritis. Kidney Int. 28:513. 
26.  Floege,  J., M.W. Burns, C.E. Alpers, A. Yoshimura, P. Pritzl, 
K. Gordon, R.A. Seifert, D.E Bowen-Pope,  W.G. Couser, and 
R.J. Johnson.  1992. Glomerular cell proliferation and PDGF 
expression precede glomerulosclerosis  in the remnant kidney 
model. Kidney Int. 41:297. 
27.  Holdsworth, S.R., N.M. Thomson, E.F. Glasgow, and R.C. 
Atkins. 1979. The effect of defibrination on macrophage par- 
ticipation in rabbit nephrotoxic nephritis: studies using glo- 
merular culture and electronmicroscopy.  Clin. Exp. Immunol. 
37:38. 
28,  Rovin, B.H., and L.C. Tan. 1993. LDL stimulates mesangial 
fibronectin production and chemoattractant expression. Kidney 
Int.  43:218. 
29.  Bar-Shavit, R., A. Kahn, J.W. Fenton II, and G.D. Wilner. 
1983. Chemotactic response of monocytes to thrombin.J. Cell 
Biol. 96:282. 
1741  Grandaliano  et al.  Brief  Definitive Report 